Gabrail Cancer Institute is a clinical research site located in Canton, Ohio, United States 44718.
Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.
Gabrail Cancer Institute has participated in 2 clinical trials.
Therapeutic areas: Melanoma, Head and Neck Cancer, Non Small Cell Lung Cancer.
Sponsors: MacroGenics, Aileron Therapeutics, Inc..
Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Gabrail Cancer Institute has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Gabrail Cancer Institute has 2 clinical trials on record. Their work covers Melanoma, Head and Neck Cancer, Non Small Cell Lung Cancer.
Gabrail Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.